LINC00853 is likely to act independently of AFP, and thus, it may be a more useful biomarker in patients with CH or LC who sometimes exhibit elevated AFP levels in the absence of HCC, leading to false‐positive results. This evidence concerns the gene AFP and cyclic hematopoiesis.